Establishment and Validation of a Prognostic Immune Signature in Neuroblastoma

BACKGROUND: Neuroblastoma (NBL) is the most common extracranial solid tumor in childhood, and patients with high-risk neuroblastoma had a relatively poor prognosis despite multimodal treatment. To improve immunotherapy efficacy in neuroblastoma, systematic profiling of the immune landscape in neurob...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yunhu, Zeng, Yu, Xia, Xiangping, Zhou, Jian-Guo, Cao, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477712/
https://www.ncbi.nlm.nih.gov/pubmed/34569303
http://dx.doi.org/10.1177/10732748211033751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477712/
https://www.ncbi.nlm.nih.gov/pubmed/34569303
http://dx.doi.org/10.1177/10732748211033751

Ejemplares similares